EdgarLookup
4

4 Filing

Company
Sonoma Pharmaceuticals, Inc.
Filed
July 3, 2023
Period of Report
June 30, 2023
Accession Number
0001683168-23-004631
View Document ↗ View on SEC.gov ↗